CA2012791C - Base de gel en aerosol et preparation de gel en aerosol - Google Patents

Base de gel en aerosol et preparation de gel en aerosol

Info

Publication number
CA2012791C
CA2012791C CA002012791A CA2012791A CA2012791C CA 2012791 C CA2012791 C CA 2012791C CA 002012791 A CA002012791 A CA 002012791A CA 2012791 A CA2012791 A CA 2012791A CA 2012791 C CA2012791 C CA 2012791C
Authority
CA
Canada
Prior art keywords
spray
viscosity
gel
vaccine
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002012791A
Other languages
English (en)
Other versions
CA2012791A1 (fr
Inventor
Takuzo Kamishita
Takashi Miyazaki
Yoshihide Okuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toko Yakuhin Kogyo KK
Original Assignee
Toko Yakuhin Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1086339A external-priority patent/JPH0623094B2/ja
Priority claimed from JP17258289A external-priority patent/JPH0678245B2/ja
Application filed by Toko Yakuhin Kogyo KK filed Critical Toko Yakuhin Kogyo KK
Publication of CA2012791A1 publication Critical patent/CA2012791A1/fr
Application granted granted Critical
Publication of CA2012791C publication Critical patent/CA2012791C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002012791A 1989-04-05 1990-03-22 Base de gel en aerosol et preparation de gel en aerosol Expired - Lifetime CA2012791C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP86339/1989 1989-04-05
JP1086339A JPH0623094B2 (ja) 1989-04-05 1989-04-05 噴霧用ゲル基剤およびそれを用いたゲル剤
JP172582/1989 1989-07-04
JP17258289A JPH0678245B2 (ja) 1989-07-04 1989-07-04 鼻腔内噴霧投与用インフルエンザワクチンゲル製剤

Publications (2)

Publication Number Publication Date
CA2012791A1 CA2012791A1 (fr) 1990-10-05
CA2012791C true CA2012791C (fr) 1997-12-23

Family

ID=26427479

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002012791A Expired - Lifetime CA2012791C (fr) 1989-04-05 1990-03-22 Base de gel en aerosol et preparation de gel en aerosol

Country Status (10)

Country Link
US (1) US5158761A (fr)
EP (1) EP0391342B1 (fr)
CN (1) CN1046097A (fr)
AT (1) ATE101797T1 (fr)
AU (1) AU625118B2 (fr)
CA (1) CA2012791C (fr)
DE (1) DE69006760T2 (fr)
DK (1) DK0391342T3 (fr)
ES (1) ES2051404T3 (fr)
RU (1) RU2028146C1 (fr)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776493A (en) * 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
IT1247138B (it) * 1991-03-06 1994-12-12 Dompe Farmaceutici Spa Composizione farmaceutica idrofila contenente ketoprofene sale di lisina per uso topico.
US5248310A (en) * 1992-03-27 1993-09-28 Alza Corporation Oral osmotic device with hydrogel driving member
US5512299A (en) * 1992-03-30 1996-04-30 Alza Corporation Method of treating oral inflammatory disease
US5376366A (en) * 1992-11-12 1994-12-27 John Petchul Composition and process for forming isopropyl alcohol gel with water-soluble vinyl polymer neutralizing agent
US5573776A (en) * 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
JP2533723B2 (ja) * 1992-12-28 1996-09-11 東興薬品工業株式会社 速乾性ゲルタイプ手指消毒剤
BR9405996A (pt) * 1993-03-11 1995-12-19 Secretech Inc Mucoadesivos poliméricos na distribuição de imunógenos em superfícies mucosais
US5500205A (en) * 1994-02-23 1996-03-19 Enviro Pac International, L.I.C. Lachrymator aerosol formulations
GB9408545D0 (en) * 1994-04-29 1994-06-22 Zyma Sa Compositions
CA2201358C (fr) * 1994-09-30 2004-06-08 Jurgen Regenold Composition pharmaceutique
JP3098401B2 (ja) * 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
PT885002E (pt) * 1996-03-04 2011-07-14 Massachusetts Inst Technology Materiais e métodos para aumento da internalização celular
JP3020141B2 (ja) * 1996-10-07 2000-03-15 株式会社富士薬品 経鼻投与用製剤
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
EP1117378A2 (fr) 1998-10-05 2001-07-25 The Penn State Research Foundation Compositions et procedes permettant d'augmenter l'internalisation cellulaire a mediation par les recepteurs
WO2001017556A1 (fr) * 1999-09-07 2001-03-15 Shionogi & Co., Ltd. Préparations vaccinales administrables par les muqueuses
US6398774B1 (en) 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system
US7678087B2 (en) * 1999-09-29 2010-03-16 Heska Corporation Equine intranasal delivery system
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
US20040234457A1 (en) * 1999-10-19 2004-11-25 The Procter & Gamble Company Methods of preventing and treating SARS using low pH respiratory tract compositions
US6387858B1 (en) 2000-03-31 2002-05-14 Steris Inc. Safe transport gel for treating medical instruments
EP1421940A4 (fr) * 2001-08-09 2006-02-08 Sekisui Chemical Co Ltd Composition medicale a usage externe destinee au traitement des dermatoses
WO2004024187A2 (fr) * 2002-09-13 2004-03-25 Zicam, Llc. Compositions pouvant reduire la congestion nasale et procedes d'application de ces compositions sur la membrane nasale
AU2003268704A1 (en) * 2002-10-01 2004-04-23 Taisho Pharmaceutical Co., Ltd. Nasal drop composition
US20050220777A1 (en) * 2003-11-21 2005-10-06 Stefan Roos Selection of lactic acid bacteria enhancing the immune response against Streptococcus pneumoniae
EP1732577B1 (fr) * 2004-02-23 2013-04-10 Strategic Science & Technologies, LLC Administration topique de l-arginine, destinee a ameliorer l'aspect du corps et de la peau
CA2738682A1 (fr) 2004-04-15 2005-10-15 Eng-Hong Lee Dispositif d'administration de gel doux pour le traitement de la volaille
EP2417978A1 (fr) * 2004-04-19 2012-02-15 Strategic Science & Technologies, LLC Effets bénéfiques de l'augmentation du débit sanguin local
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
ES2429443T3 (es) * 2004-04-19 2013-11-14 Strategic Science & Technologies, Llc Suministro transdérmico de sustancias beneficiosas efectuado mediante un entorno de fuerza iónica elevada
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
JP5577021B2 (ja) 2005-02-17 2014-08-20 アボット・ラボラトリーズ 動物における障害を治療および予防するための薬剤組成物の経粘膜投与
US20070059250A1 (en) * 2005-09-12 2007-03-15 Nawaz Ahmad Sprayable personal lubricant
US20070110676A1 (en) * 2005-11-17 2007-05-17 The Procter & Gamble Company Compositions useful for prevention and treatment of common cold and influenza-like symptoms
GB0604319D0 (en) * 2006-03-03 2006-04-12 Optinose As Nasal delivery
SI2011467T1 (sl) * 2006-04-21 2021-01-29 Toko Yakuhin Kogyo Kabushiki Kaisha Posoda za tekočino in brezzračni sistem za razdeljevanje tekočine
RU2434652C2 (ru) * 2006-04-21 2011-11-27 Токо Якухин Когио Кабусики Кайся Емкость для текучей среды и система безвоздушного дозирования текучей среды с использованием упомянутой емкости
US20080299182A1 (en) * 2007-03-01 2008-12-04 Shuyuan Zhang Methods and formulations for topical gene therapy
PE20091174A1 (es) * 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd Formulacion liquida con contenido de alta concentracion de anticuerpo
WO2010114169A1 (fr) 2009-03-31 2010-10-07 Japan As Represented By The Director-General Of National Institute Of Infectious Diseases Méthode de prophylaxie de la grippe utilisant un vaccin à administration intranasale
US9072659B2 (en) 2009-06-24 2015-07-07 Strategic Science & Technologies, Llc Topical composition containing naproxen
KR101643797B1 (ko) 2009-06-24 2016-07-28 스트러티직 사이언스 앤드 테크놀로지스, 엘엘씨 이부프로펜을 함유하는 국소 조성물
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
KR101751376B1 (ko) * 2010-03-02 2017-07-11 오요 코소 이가쿠 켄큐죠 가부시키가이샤 점막 백신
US8916171B2 (en) * 2010-04-27 2014-12-23 Topical Sinus Therapeutics, Inc. Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis
JP2014504592A (ja) 2010-12-29 2014-02-24 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 勃起不全および他の適応症の処置
JP2014501283A (ja) 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー アレルギーおよび他の適応症の処置のためのシステムおよび方法
RU2600796C2 (ru) 2011-05-04 2016-10-27 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Местный состав, содержащий кортикостероид в качестве активного ингредиента
JP6085886B2 (ja) * 2011-08-29 2017-03-01 国立大学法人徳島大学 Ｒｓｖ粘膜ワクチン
DK2939692T3 (da) * 2012-12-28 2019-07-08 Japan As Represented By Director General Of Nat Institute Of Infectious Diseases Nasal influenzavaccinesammensætning
CN106573045B (zh) * 2014-06-25 2020-10-27 东兴药品工业株式会社 流感疫苗经鼻接种系统
EP3331888A4 (fr) * 2015-08-03 2019-03-20 Synergistic Therapeutics, LLC Gel thérapeutique pour dysfonctionnement sexuel
JP6629877B2 (ja) * 2015-10-30 2020-01-15 帝人ファーマ株式会社 鼻粘膜投与用医薬組成物
MX2020003753A (es) 2017-10-05 2020-11-09 Toko Yakuhin Kogyo Kk Composicion nasal de vacuna contra hepatitis b y metodo para producir la misma.
CN114585715A (zh) 2019-11-19 2022-06-03 西姆莱斯有限公司 家庭护理产品或制剂
US20230018472A1 (en) * 2019-12-06 2023-01-19 Toko Yakuhin Kogyo Co., Ltd. Rhinenchysis composition containing olopatadine

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195076A (en) * 1974-03-05 1980-03-25 Science Union Et Cie, Societe Francaise De Recherche Medicale Process for the preparation of hemagglutinin from viral sources and methods of utilizing same
US3940351A (en) * 1974-07-02 1976-02-24 The B. F. Goodrich Company Polymerization of carboxylic acid monomers and alkyl acrylate esters in chlorofluoroethane
JPS5144618A (en) * 1974-10-07 1976-04-16 Toko Yakuhin Kogyo Kk Kyokushoyozaino seizoho
JPS5467022A (en) * 1977-11-07 1979-05-30 Toko Yakuhin Kogyo Kk Topical agent and production thereof
US4267169A (en) * 1978-07-22 1981-05-12 Toko Yakuhin Kogyo Kabushiki Kaisha Novel preparation of clotrimazole
CA1146866A (fr) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Procede de production d'un compose pharmaceutique a liberation continue sous forme solide
US4512972A (en) * 1980-06-30 1985-04-23 Kureha Chemical Industry Co., Ltd. Nasal preparation and processes for their production
US4625015A (en) * 1982-08-23 1986-11-25 Scripps Clinic & Research Foundation Broad spectrum influenza antisera
US4495168A (en) * 1983-08-22 1985-01-22 Basf Wyandotte Corporation Aerosol gel
US4717566A (en) * 1984-03-19 1988-01-05 Alza Corporation Dosage system and method of using same
JPS6147186A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
DE3586713T2 (de) * 1984-11-15 1993-05-13 Hercon Lab Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen.
DE3600263A1 (de) * 1986-01-08 1987-07-09 Hoechst Ag Mit fettsaeuren modifizierte polyester, verfahren zu deren herstellung und deren verwendung zur erhoehung der viskositaet in tensidhaltigen praeparaten
JPS63174924A (ja) * 1987-01-14 1988-07-19 Toko Yakuhin Kogyo Kk 軟膏基剤および軟膏剤
US4883660A (en) * 1988-10-17 1989-11-28 Thames Pharmacal Co., Inc. Gel bases for pharmaceutical compositions

Also Published As

Publication number Publication date
DK0391342T3 (da) 1994-03-28
ES2051404T3 (es) 1994-06-16
DE69006760D1 (de) 1994-03-31
EP0391342B1 (fr) 1994-02-23
DE69006760T2 (de) 1994-09-08
AU5290490A (en) 1990-10-11
EP0391342A1 (fr) 1990-10-10
ATE101797T1 (de) 1994-03-15
CN1046097A (zh) 1990-10-17
US5158761A (en) 1992-10-27
AU625118B2 (en) 1992-07-02
RU2028146C1 (ru) 1995-02-09
CA2012791A1 (fr) 1990-10-05

Similar Documents

Publication Publication Date Title
CA2012791C (fr) Base de gel en aerosol et preparation de gel en aerosol
US5215739A (en) Spray gel base and spray gel preparation using thereof
RU2438710C2 (ru) Пригодный к распылению адгезивный к коже/слизистой оболочке препарат гелевого типа и система для введения с использованием препарата
ES2205177T5 (es) Composicion en polvo para administracion nasal.
CN105491982B (zh) 用于增强透皮递送的肽
CA2294457C (fr) Compositions pharmaceutiques a appliquer sur la muqueuse
HUT63539A (en) Bioactive compositions and process for forming bioactive coatings
JPS61267528A (ja) 吸収促進剤を含有するカルシトニン経鼻剤
JP2020073615A (ja) ロキソプロフェンを含有する医薬製剤（に）
KR0137206B1 (ko) 분무용 겔 기제와 이것을 사용한 분무용 겔제
JPH0678245B2 (ja) 鼻腔内噴霧投与用インフルエンザワクチンゲル製剤
TWI327913B (en) Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
JP5095239B2 (ja) ジェルスプレー用エアゾール組成物
JP2011046666A (ja) 医薬組成物
JPS63101318A (ja) 点鼻剤
JPH01160916A (ja) ドーパミン経鼻投与製剤
JP3095488B2 (ja) 噴霧用ゲル基剤およびそれを用いた噴霧用点鼻剤
US11491219B2 (en) Nasal hepatitis B vaccine composition and method for producing same
JP2003055201A (ja) ビタミンａ類含有可溶化組成物及びビタミンａ類の安定化方法
JPH07316038A (ja) 粘膜投与用薬剤組成物
JPS6339822A (ja) カルシトニン経鼻剤
JPS63258821A (ja) 鼻腔内投与用薬剤組成物
JPH0383931A (ja) 低刺激性ｇｒｆ経鼻投与製剤
Bhuva et al. Pediatric nasal spray solution: factorial design development and evaluation
RU2773357C2 (ru) Назальная вакцинная композиция против гепатита b и способ ее получения

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry